%0 Journal Article
%T Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence
%J Archive of "Neuropsychopharmacology".
%D 2018
%R 10.1038/npp.2017.245
%X Correction to: Neuropsychopharmacology advance online publication, 27 September 2017; doi: 10.1038/npp.2017.20
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809793/